Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Taylor

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
BMJ (Clinical Research Ed.)|October 18, 2008
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial diseaseJill Belch, Angus MacCuish, Iain Campbell, et al.
Lancet (London, England)|March 27, 2007
Modernising medical careers, medical training application service, and the postgraduate medical education and training board: time for the emperors to don their clothesMorris Brown, Nick Boon, Nick Brooks, et al.
Lancet (London, England)|May 22, 2007
Medical training in the UK: sleepwalking to disasterMorris Brown, Nick Boon, Nick Brooks, et al.
Plos Medicine|February 1, 2008
A prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and miceDavid B Savage, Lanmin Zhai, Balasubramanian Ravikumar, et al.
Diabetologia|December 1, 2017
Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohortRoy Taylor, Wilma S Leslie, Alison C Barnes, et al.
The Lancet. Diabetes & Endocrinology|March 11, 2019
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trialMichael E J Lean, Wilma S Leslie, Alison C Barnes, et al.
Lancet (London, England)|December 10, 2017
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trialMichael Ej Lean, Wilma S Leslie, Alison C Barnes, et al.
Science Translational Medicine|April 6, 2022
A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in riskStephen A Williams, Rachel Ostroff, Michael A Hinterberg, et al.
United European Gastroenterology Journal|February 14, 2026
International Multidisciplinary Consensus Report on Definitions, Diagnostic Criteria, and Management of Fatty Pancreas: A Joint Statement Endorsed by EPC, APA, EASD, EASL, ESGAR, ESGE, ESP, ESPCG, ESPEN, ESPGHAN, IAP, JPS, KPBA, LAPSG, and UEGMiroslav Vujasinovic, Ihsan Ekin Demir, Giovanni Marchegiani, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
BMJ (Clinical Research Ed.)|October 18, 2008
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial diseaseJill Belch, Angus MacCuish, Iain Campbell, et al.
Lancet (London, England)|March 27, 2007
Modernising medical careers, medical training application service, and the postgraduate medical education and training board: time for the emperors to don their clothesMorris Brown, Nick Boon, Nick Brooks, et al.
Lancet (London, England)|May 22, 2007
Medical training in the UK: sleepwalking to disasterMorris Brown, Nick Boon, Nick Brooks, et al.
Plos Medicine|February 1, 2008
A prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and miceDavid B Savage, Lanmin Zhai, Balasubramanian Ravikumar, et al.
Diabetologia|December 1, 2017
Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohortRoy Taylor, Wilma S Leslie, Alison C Barnes, et al.
The Lancet. Diabetes & Endocrinology|March 11, 2019
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trialMichael E J Lean, Wilma S Leslie, Alison C Barnes, et al.
Lancet (London, England)|December 10, 2017
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trialMichael Ej Lean, Wilma S Leslie, Alison C Barnes, et al.
Science Translational Medicine|April 6, 2022
A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in riskStephen A Williams, Rachel Ostroff, Michael A Hinterberg, et al.
United European Gastroenterology Journal|February 14, 2026
International Multidisciplinary Consensus Report on Definitions, Diagnostic Criteria, and Management of Fatty Pancreas: A Joint Statement Endorsed by EPC, APA, EASD, EASL, ESGAR, ESGE, ESP, ESPCG, ESPEN, ESPGHAN, IAP, JPS, KPBA, LAPSG, and UEGMiroslav Vujasinovic, Ihsan Ekin Demir, Giovanni Marchegiani, et al.
Pageof 15